versión imprimible
 
 

2nd Gene Therapy for Ophthalmic Disorders

Evvnt Promotion / evvnt
-
21.09.2021 - 23.09.2021  Online
Time: 8:00 am - 5:00 pm
 
Temas de la conferencia
Returning in September as a digital event, the 2nd Gene Therapy for Ophthalmic Disorders meeting will target the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more.

Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.
La Sociedad Científica
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/780504-0?pid=4832

Speakers: Nicolas Ferry, Chief Development Officer, HORAMA, Rei Nakamura, Clinical Country Lead, Biogen and more
 

Información e inscripción:

https://go.evvnt.com/780504-1?pid=4832
Ms. Ellie Saunders
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 1599.00 - USD 3296.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Alumni Club Medizinische Universität WienEuropean Public Health Association (EUPHA)Österreichische Gesellschaft für Public HealthÄrztekammer für WienÖsterreichisches Rotes KreuzAnästhesie in Entwicklungsländern e. V.Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario